Moderna Executive and Leadership Team

Jamey Mock, the Chief Financial Officer at Moderna, directs the global financial strategy and capital allocation processes. Overseeing fiscal planning, the Chief Financial Officer ensures the company maintains the necessary liquidity to fund extensive mRNA research and development pipelines. This leadership role involves managing investor relations and providing transparent reporting on the financial health of the organization. By optimizing cost structures and resource distribution, Jamey Mock directly impacts the ability of the company to scale manufacturing capabilities across North American and international markets. The Chief Financial Officer collaborates with the board to align long-term investment goals with the mission of delivering life-saving medicines. Through rigorous financial oversight, Mock secures the stability required for sustained growth in the competitive pharmaceutical landscape, ensuring that every dollar invested advances the scientific frontier of mRNA technology.

Kei Kaneda, the Representative Director & President at Moderna, leads the strategic direction and organizational growth within the Japanese market. Overseeing regional operations, the Representative Director & President ensures that the company mission of mRNA innovation translates into effective local healthcare solutions. This leadership role involves building strong relationships with regulatory bodies and medical institutions to facilitate the adoption of new vaccines and therapies. By driving regional business development, Kei Kaneda expands the footprint of the company in the Asia-Pacific region. The Representative Director & President collaborates with global leadership to ensure that local market insights inform the broader corporate strategy. Through visionary leadership and operational focus, Kaneda strengthens the position of the company as a leader in biotechnology, ensuring that the unique benefits of mRNA medicine are accessible to patients and healthcare providers throughout the region, thereby contributing to the global impact of the organization.

Sam Ismail, the Chief Marketing Officer & Senior Analyst at Moderna, architects the commercialization strategies for mRNA-based therapeutic platforms. Overseeing market intelligence, the Chief Marketing Officer & Senior Analyst evaluates emerging trends in infectious disease prevention to guide product positioning. This leadership role involves synthesizing complex clinical data into actionable insights for global stakeholders. By analyzing competitive landscapes, Sam Ismail drives the adoption of new medical solutions across diverse healthcare systems. The Chief Marketing Officer & Senior Analyst coordinates with research teams to ensure that market demand informs the development of future vaccine candidates. Through strategic communication and data-driven forecasting, Ismail expands the reach of the company, ensuring that innovative treatments effectively address unmet patient needs. This focus on market penetration and analytical rigor supports the broader objective of transforming global health outcomes through advanced biotechnology.

Sameh Ismail, the Chief Marketing Officer & Senior Analyst at Moderna, manages the strategic outreach and brand positioning for the company's oncology portfolio. Overseeing patient advocacy initiatives, the Chief Marketing Officer & Senior Analyst ensures that the value proposition of mRNA cancer treatments reaches clinical providers and healthcare systems worldwide. This leadership role involves conducting deep-dive analyses into regional market access barriers to facilitate smoother product launches. By leveraging advanced analytics, Sameh Ismail identifies key growth opportunities within the autoimmune and rare disease sectors. The Chief Marketing Officer & Senior Analyst collaborates with cross-functional teams to refine messaging that highlights the unique scientific advantages of the mRNA platform. Through persistent market evaluation and strategic planning, Ismail strengthens the presence of the company in international markets, ultimately driving the successful integration of novel therapies into standard clinical practice.

Richard Mason, the Senior Specialist, External Manufacturing - Chief Marketing Officer Operations at Moderna, coordinates the complex logistics required for global vaccine production. Overseeing external manufacturing partnerships, the Senior Specialist, External Manufacturing - Chief Marketing Officer Operations ensures that production capacity meets the rigorous quality standards necessary for mRNA medicine. This leadership role involves managing relationships with contract manufacturing organizations to maintain a resilient supply chain. By streamlining operational workflows, Richard Mason facilitates the rapid scaling of manufacturing processes during critical health crises. The Senior Specialist, External Manufacturing - Chief Marketing Officer Operations integrates supply chain data with marketing operational requirements to ensure product availability aligns with global demand. Through meticulous oversight of external production facilities, Mason supports the mission of the company to deliver high-quality, life-saving treatments to patients across the globe, ensuring operational excellence at every stage of the manufacturing lifecycle.

Paula Rodrguez, the Senior Chief Marketing Officer, Operations & Specialist at Moderna, directs the operational infrastructure supporting the commercialization of mRNA vaccines. Overseeing internal process optimization, the Senior Chief Marketing Officer, Operations & Specialist ensures that marketing teams possess the tools and data required for effective regional execution. This leadership role involves harmonizing operational workflows across diverse geographic territories to maintain brand consistency. By implementing advanced project management systems, Paula Rodrguez enhances the efficiency of marketing campaigns targeting infectious disease prevention. The Senior Chief Marketing Officer, Operations & Specialist collaborates with technical teams to translate complex scientific data into clear, accessible information for healthcare providers. Through strategic operational oversight, Rodrguez drives the successful deployment of marketing initiatives, ensuring that the company maintains a strong, reliable presence in the global pharmaceutical market while supporting the overarching goal of improving human health.

Michael Aihe, the Manager, Chief Marketing Officer Planning, Supply Chain at Moderna, synchronizes supply chain logistics with commercial planning to ensure the timely delivery of mRNA products. Overseeing inventory distribution, the Manager, Chief Marketing Officer Planning, Supply Chain ensures that market demand forecasts directly inform production schedules. This leadership role involves managing the flow of materials and finished goods across international borders to support global health initiatives. By optimizing supply chain visibility, Michael Aihe reduces bottlenecks that could impede the distribution of vaccines and therapeutics. The Manager, Chief Marketing Officer Planning, Supply Chain collaborates with manufacturing and marketing departments to align operational output with strategic growth targets. Through precise planning and logistical coordination, Aihe ensures that the company maintains a robust supply chain capable of responding to the dynamic needs of the healthcare industry, ultimately supporting the mission of delivering innovative medicine to patients worldwide.

Jeffrey Salling, the Chief of Staff & Operations Senior Director, Legal at Moderna, manages the intersection of corporate governance and operational execution. Overseeing legal compliance, the Chief of Staff & Operations Senior Director, Legal ensures that all strategic initiatives align with regulatory requirements and internal policies. This leadership role involves facilitating communication between the executive team and the board to streamline decision-making processes. By providing legal oversight for operational projects, Jeffrey Salling mitigates risks associated with the rapid development of mRNA technologies. The Chief of Staff & Operations Senior Director, Legal coordinates cross-departmental efforts to ensure that legal frameworks support the innovative mission of the company. Through diligent management of corporate operations and legal affairs, Salling maintains the integrity of the organization, ensuring that all business activities remain focused on the long-term goal of transforming medicine and improving patient outcomes on a global scale.